We are live on
!
Find out more
AA
Antipodean Advisors Portfolio holdings
AUM
$19.5M
1-Year Est. Return
6.21%
This Fund
S&P 500
This Quarter
Est. Return
+0.57%
1 Year Est. Return
-6.21%
3 Year Est. Return
-67.79%
5 Year Est. Return
+67.26%
10 Year Est. Return
+1,117.22%
AUM
$1.03B
AUM Growth
-$312M
(-23%)
Cap. Flow
-$279M
Cap. Flow
% of AUM
-27.22%
Top 10 Holdings %
Top 10 Hldgs %
69.62%
Holding
32
New
11
Increased
3
Reduced
12
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Air Products & Chemicals
APD
|
+$46.1M |
| 2 |
Dollar General
DG
|
+$37.1M |
| 3 |
Dollar Tree
DLTR
|
+$30.9M |
| 4 |
Alibaba
BABA
|
+$18.1M |
| 5 |
DigitalBridge
DBRG
|
+$16.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ENDP
Endo International plc
ENDP
|
+$73.9M |
| 2 |
Bausch Health
BHC
|
+$61.6M |
| 3 |
Charter Communications
CHTR
|
+$60.9M |
| 4 |
Workday
WDAY
|
+$58.9M |
| 5 |
Constellation Brands
STZ
|
+$42.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.75% |
| 2 | Energy | 18.51% |
| 3 | Technology | 14.04% |
| 4 | Consumer Staples | 12.7% |
| 5 | Consumer Discretionary | 10.56% |
Similar funds
CVSCT
DOS
SIC
LUGPI
RCP
IVM
CCFM
VNB
Antipodean Advisors's Q3 2014 Portfolio in Review
As of Q3 2014, Antipodean Advisors held 32 positions worth $1.03B, down 23% from $1.34B the previous quarter. Its ten largest holdings account for 70% of the portfolio.
Antipodean Advisors withdrew a net $279M in Q3 2014, closing 6 positions and reducing 12 holdings. Its most notable exit was Endo International plc, an estimated $73.9M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 34% a quarter earlier, followed by Energy and Technology.
Against the trend, Antipodean Advisors opened a new position in Air Products & Chemicals worth $45.4M.
- Antipodean Advisors's largest Q3 2014 buy was Air Products & Chemicals: 377,269 shares worth $45.4M.
- Antipodean Advisors added most to H&R Block in Q3 2014, an estimated $9.32M increase.
- Antipodean Advisors's biggest Q3 2014 reduction was Bausch Health, cutting an estimated $61.6M.
- Antipodean Advisors fully exited Endo International plc in Q3 2014, selling an estimated $73.9M.
- Antipodean Advisors's ten largest holdings make up 70% of its $1.03B portfolio in Q3 2014.
- Antipodean Advisors opened 11 new positions and closed 6 in Q3 2014.
- Antipodean Advisors's portfolio value fell 23% quarter-over-quarter to $1.03B.
Based on Antipodean Advisors's 13F filing for Q3 2014, filed 14 Nov 2014.